Binding affinity is the quantitative measure of the strength of the interaction between a single biomolecule and its ligand, expressed through the equilibrium dissociation constant (Kd) or inhibition constant (Ki). A lower Kd value signifies a higher, tighter binding affinity, reflecting a greater proportion of occupied target protein at a given ligand concentration.
Glossary
Binding Affinity

What is Binding Affinity?
Binding affinity quantifies the strength of the reversible, non-covalent interaction between a biomolecule, typically a protein, and its ligand.
This thermodynamic parameter is governed by the Gibbs free energy change (ΔG) of binding, which is the sum of enthalpic contributions from hydrogen bonds and van der Waals contacts, and entropic changes from the displacement of ordered water molecules. Accurate prediction of binding affinity is the central objective of drug-target interaction modeling, directly correlating with a compound's in vivo efficacy and driving the prioritization of lead candidates in virtual screening campaigns.
Core Characteristics of Binding Affinity
Binding affinity quantifies the strength of a non-covalent interaction between a biomolecule and its ligand. It is governed by a delicate interplay of enthalpic and entropic contributions, expressed through equilibrium constants and free energy landscapes.
The Thermodynamic Dissociation Constant (Kd)
The dissociation constant (Kd) is the gold-standard measure of affinity, representing the ligand concentration at which half the target's binding sites are occupied. A lower Kd indicates higher affinity.
- Formula: Kd = [P][L] / [PL]
- Units: Molar (M), typically ranging from mM (weak) to pM (ultra-tight)
- Relationship: Kd is the reciprocal of the association constant (Ka)
- Measurement: Determined via Surface Plasmon Resonance (SPR), Isothermal Titration Calorimetry (ITC), or radioligand binding assays
- Example: Biotin-streptavidin complex exhibits a Kd of ~10⁻¹⁴ M, one of the strongest known non-covalent interactions
Gibbs Free Energy of Binding (ΔG)
The Gibbs free energy change (ΔG) upon binding determines spontaneity and is directly related to Kd. A more negative ΔG signifies a more favorable, higher-affinity interaction.
- Equation: ΔG = -RT ln(Ka) = RT ln(Kd)
- Components: ΔG = ΔH - TΔS, where ΔH is enthalpy change and ΔS is entropy change
- Energy Scale: A ΔG of -10 kcal/mol corresponds to a Kd of ~50 nM at 298 K
- Enthalpy-Driven: Dominated by favorable hydrogen bonds, van der Waals contacts, and electrostatic interactions
- Entropy-Driven: Driven by the hydrophobic effect and release of ordered water molecules from the binding interface
Enthalpy-Entropy Compensation
Enthalpy-entropy compensation is the observed phenomenon where favorable enthalpic gains from forming intermolecular bonds are often offset by unfavorable entropic losses from conformational restriction, and vice versa.
- Mechanism: Stronger binding interactions (favorable ΔH) rigidify the complex (unfavorable -TΔS)
- Solvent Reorganization: Release of structured water from hydrophobic surfaces is entropically favorable but enthalpically neutral or slightly unfavorable
- Drug Design Implication: Optimizing for enthalpy-driven binders often yields higher selectivity, as entropic contributions from desolvation are less target-specific
- ITC Deconvolution: Isothermal Titration Calorimetry uniquely measures ΔH and ΔS independently, revealing the thermodynamic signature of binding
Kinetics: Association and Dissociation Rates
Binding affinity is a ratio of kinetic rate constants. The association rate (kon) and dissociation rate (koff) define how quickly a complex forms and decays, with Kd = koff / kon.
- kon: Diffusion-limited maximum ~10⁸ to 10⁹ M⁻¹s⁻¹; influenced by electrostatic steering and conformational selection
- koff: Ranges from milliseconds (weak binders) to days (tight binders); the primary determinant of residence time
- Residence Time (τ): τ = 1/koff; often correlates better with in vivo efficacy than Kd alone
- SPR Biosensors: Surface Plasmon Resonance provides real-time kon and koff measurements without labels
- Clinical Relevance: Drugs with long residence times (slow koff) can maintain target engagement even after plasma clearance
The Role of Solvation and Desolvation
Desolvation is the energetic cost of stripping water molecules from the binding interfaces of both protein and ligand before complex formation. This process profoundly influences the net binding free energy.
- Hydrophobic Effect: Burial of non-polar surface area releases ordered water into bulk solvent, providing a favorable entropic driving force
- Polar Desolvation Penalty: Removing water from charged or polar groups is energetically costly and must be compensated by new hydrogen bonds in the complex
- Water Networks: Structured water molecules bridging protein and ligand can contribute favorably to binding enthalpy if optimally positioned
- Computational Prediction: Implicit solvation models (GBSA, PBSA) approximate these effects, while explicit solvent molecular dynamics provide detailed water maps
IC50 and EC50: Functional Affinity Measures
IC50 (half-maximal inhibitory concentration) and EC50 (half-maximal effective concentration) are functional measures of a compound's potency, which depend on both binding affinity and downstream cellular context.
- IC50: Concentration required to inhibit a biological process by 50%; commonly used in enzyme and cell-based assays
- EC50: Concentration producing 50% of the maximal response; used for agonists and activators
- Cheng-Prusoff Equation: Relates IC50 to Ki (inhibition constant) for competitive inhibitors: Ki = IC50 / (1 + [S]/Km)
- Assay Dependency: IC50 values vary with substrate concentration, incubation time, and cell type, unlike the system-independent Kd
- Caution: IC50 is not a direct measure of binding affinity; it conflates target engagement with functional pathway amplification
Frequently Asked Questions
Explore the fundamental thermodynamic and kinetic principles governing the strength of interaction between a biomolecule and its ligand, and how these concepts are computationally modeled in modern drug discovery.
Binding affinity is the quantitative strength of the non-covalent interaction between a single biomolecule (typically a protein) and its ligand (a small molecule or another biomolecule). It is formally defined by the equilibrium dissociation constant, K<sub>d</sub>, which represents the ligand concentration at which half of the available binding sites are occupied at equilibrium. A lower K<sub>d</sub> value indicates a higher affinity, with values often ranging from millimolar (10<sup>-3</sup> M, weak) to picomolar (10<sup>-12</sup> M, extremely tight). The relationship is thermodynamic: the Gibbs free energy of binding (ΔG) is related to K<sub>d</sub> by the equation ΔG = RT ln(Kd), where R is the gas constant and T is the absolute temperature. Alternative metrics include the inhibition constant (K<sub>i</sub>) for competitive inhibitors and the half-maximal inhibitory concentration (IC<sub>50</sub>), though the latter is assay-dependent and not a true thermodynamic constant.
Binding Affinity vs. Related Metrics
A comparison of binding affinity with other quantitative measures used to characterize drug-target interactions and pharmacological potency.
| Metric | Binding Affinity | Scoring Function | IC50 / EC50 | Residence Time |
|---|---|---|---|---|
Primary Definition | Thermodynamic strength of a single non-covalent binding event | Mathematical approximation of binding free energy for pose ranking | Concentration of drug required for 50% inhibition or effect in a functional assay | Average duration a ligand remains bound to its target |
Fundamental Unit | Kd, Ki, or ΔG (kcal/mol) | Arbitrary score or estimated ΔG (kcal/mol) | Molar concentration (nM, μM) | Time (seconds, minutes) |
Measurement Context | Biophysical assay (SPR, ITC, MST) | Computational (in silico) | Biochemical or cell-based functional assay | Biophysical kinetic assay (SPR, stopped-flow) |
Captures Kinetics | ||||
Reflects In Vivo Efficacy | ||||
Directly Measured | ||||
Typical Use in Drug Discovery | Hit triage and lead optimization | Virtual screening and pose prediction | Potency ranking and SAR analysis | Optimization of target occupancy duration |
Thermodynamic Parameter | ΔG, ΔH, ΔS | Estimated ΔG only | Activation energy (ΔG‡) for dissociation |
Enabling Efficiency, Speed & Accuracy
Intelligent Analysis, Decision & Execution
We build AI systems for teams that need search across company data, workflow automation across tools, or AI features inside products and internal software.
Talk to Us
Search across company data
Give teams answers from docs, tickets, runbooks, and product data with sources and permissions.
Useful when people spend too long searching or get different answers from different systems.

Automate internal workflows
Use AI to route work, draft outputs, trigger actions, and keep approvals and logs in place.
Useful when repetitive work moves across multiple tools and teams.

Add AI to products and internal tools
Build assistants, guided actions, or decision support into the software your team or customers already use.
Useful when AI needs to be part of the product, not a separate tool.
Related Terms
Binding affinity is quantified through a network of interrelated computational and experimental concepts. These terms define the methodologies used to predict, measure, and optimize the strength of a drug-target interaction.
Scoring Function
A mathematical function that approximates the binding free energy (ΔG) of a protein-ligand complex. It evaluates non-covalent interactions—such as van der Waals forces, hydrogen bonds, and electrostatic complementarity—to rank docking poses.
- Force-field-based: Calculates physical interaction energies (e.g., DOCK, AutoDock).
- Empirical: Sums weighted terms fitted to experimental affinity data (e.g., ChemScore).
- Knowledge-based: Derives statistical potentials from observed atom-pair frequencies in structural databases (e.g., PMF).
- Consensus scoring combines multiple functions to improve hit-rate enrichment.
Free Energy Perturbation (FEP)
A rigorous alchemical free energy calculation method based on statistical mechanics. FEP computes the relative binding affinity between two related ligands by simulating a non-physical thermodynamic path where one molecule is gradually 'mutated' into another.
- Achieves chemical accuracy (~1 kcal/mol) when properly converged.
- Requires extensive molecular dynamics sampling, making it computationally expensive.
- Modern GPU-accelerated implementations (e.g., Schrödinger FEP+) have made it viable for lead optimization campaigns.
MM/GBSA
Molecular Mechanics/Generalized Born Surface Area is an end-point free energy method that estimates binding affinity from only the initial and final states of a simulation—the free ligand, free protein, and the complex.
- Computationally efficient compared to FEP, requiring only a few hundred snapshots from an MD trajectory.
- Decomposes binding energy into per-residue contributions, enabling identification of hot-spot residues.
- Less accurate for absolute binding free energies but effective for ranking congeneric series.
Protein-Ligand Interaction Fingerprint
A binary or count-based vector encoding the specific intermolecular contacts between a protein's residues and a bound ligand. Each bit represents a defined interaction type at a specific residue position.
- Interaction types: Hydrogen bond donor/acceptor, hydrophobic contact, π-π stacking, salt bridge, halogen bond.
- Used as features for machine learning models predicting binding affinity or classifying active vs. inactive compounds.
- Enables interaction pattern similarity searching to find ligands with analogous binding modes regardless of chemical scaffold.
Residence Time
The reciprocal of the dissociation rate constant (koff), representing the average duration a ligand remains bound to its target. While binding affinity (Kd) reflects the equilibrium between association and dissociation, residence time captures the kinetic stability of the complex.
- τ = 1/koff: A drug with a residence time of hours may maintain target occupancy long after plasma concentration drops.
- Correlates with prolonged pharmacodynamic effects and improved in vivo efficacy.
- Optimized through structure-kinetic relationships (SKRs) rather than purely thermodynamic considerations.
Enrichment Factor
A retrospective performance metric quantifying how effectively a virtual screening method identifies active compounds early in a ranked list. It measures the fold-improvement over random selection.
- EFx% = (Actives found in top x%) / (Expected actives by random chance).
- An EF1% of 50 means the method found 50 times more actives in the top 1% of the ranked database than random screening would.
- Evaluated using decoy sets (presumed inactives with similar physical properties to known actives) to prevent artificial enrichment from trivial property discrimination.

About the author
Prasad Kumkar
CEO & MD, Inference Systems
Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.
His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.
Partnered with leading AI, data, and software stack.
How We Work
Custom AI workflows for your Business
One-fit-all AI don't work for modern businesses. At Inferensys, we aim to understand your business & custom requirements; which we use to define most efficient agentic workflows, the data, and the tools for your business.
01
Review the use case
We understand the task, the users, and where AI can actually help.
Read more02
Pick the right approach
We define what needs search, automation, or product integration.
Read more03
Build the first useful version
We implement the part that proves the value first.
Read more04
Improve from there
We add the checks and visibility needed to keep it useful.
Read moreThe first call is a practical review of your use case and the right next step.
Talk to Us